参考文献/References:
[1]王宇路,王苏平,赵雪梅,等.磁共振胰胆管成像对肿块型胰腺炎与胰腺癌的诊断价值[J].医学信息,2021,34(13):176-178.[2]张杰,李杰,毕卫群,等.CT及MRI多模态参数对鉴别胰头部肿块型慢性胰腺炎与胰头癌的价值[J].医学影像学杂志,2021,31(2):275-279.[3]顾炫,詹维伟,胡赟赟.肿块型胰腺炎与胰腺癌的超声检查鉴别诊断与分析[J].医学影像学杂志,2019,29(6):989-992.[4]Issa Y,Kempeneers MA,Van Santvoort HC,et al.Diagnostic performance of imaging modalities in chronic pancreatitis: a systematic review and meta-analysis[J].European Radiology,2017,27(9):3820-3844.[5]郝金钢,雷玉英,谭艳华,等.扩散加权成像和IVIM定量参数在胰腺癌和肿块型慢性胰腺炎定性诊断的价值[J].实用放射学杂志,2020,36(3):406-409.[6]申旭鹏,姜慧杰,李金平.CT和MRI影像技术在胰腺癌与胰腺炎性肿块鉴别诊断中的价值[J].中华全科医师杂志,2020,19(12):1189-1193.[7]冯琴,陈大勇.胰腺良恶性肿块的CT与磁共振DWI的鉴别诊断分析[J].中国继续医学教育,2020,12(31):87-90.[8]王燕,高军喜,苏力担卡扎·仇曼,等.三维与二维超声造影在胰腺癌与肿块型胰腺炎的诊断价值[J].中国超声医学杂志,2017,33(5):437-439.[9]白仲英,路勇,金媛.动态螺旋CT增强扫描影像对慢性肿块型胰腺炎的鉴别诊断价值[J].宁夏医学杂志,2020,42(8):757-759.[10]王雅杰,崔文静,陈晓,等.增强CT对乏血供胰腺神经内分泌肿瘤及肿块型胰腺炎的鉴别诊断价值[J].医学研究生学报,2020,33(7):732-736.[11]阮志兵,焦俊,闵定玉,等.多模态影像学在胰头部肿块型慢性胰腺炎与胰头导管腺癌鉴别诊断中的价值[J].中华消化杂志,2018,38(6):408-412.[12]周红云,李传稳,徐艳杰,等.Logistic回归及ROC曲线综合评价超声造影对胰腺癌诊断的应用价值[J].中国实验诊断学,2019,23(7):1160-1163.[13]贾惠惠,林光武,李仕红,等.DWI对小胰腺癌(1A期)和小肿块型局灶性胰腺炎的鉴别诊断价值[J].放射学实践,2018,33(11):1162-1166.[14]张延海,王佳冰,李文成.胰头肿块型慢性胰腺炎的CT诊断与鉴别诊断[J].中国中西医结合影像学杂志,2018,16(5):522-524.[15]丁利霞.彩色超声在胰腺癌、肿块型胰腺炎鉴别诊断中的应用[J].中国现代普通外科进展,2019,22(12):966-967,971.[16]焦芸静.彩超检查在肿块型胰腺炎和胰腺癌诊断中的应用价值分析[J].国际医药卫生导报,2018,24(7):1084-1086.[17]潘铭智,甘洁,李扬.DWI对胰腺病变的临床应用[J].中国中西医结合影像学杂志,2018,16(3):319-320,327.[18]于海霞,陈传亮,史大鹏,等.MRI在胰腺炎与胰头癌鉴别诊断中价值[J].中华实用诊断与治疗杂志,2018,32(4):378-381.[19]杨成睿,袁鹏飞.磁共振成像在胰腺癌与肿块型胰腺炎诊断中的应用价值[J].首都食品与医药,2018,25(7):51.[20]黄瑞瑜,赵仁军,许保刚,等.磁共振成像对胰腺癌与肿块型胰腺炎的诊断中的应用[J].临床和实验医学杂志,2016,15(3):284-286.[21]牛晓仙,冯丽,黄晓云.探讨超声对鉴别肿块型胰腺炎与胰腺癌的临床有效性[J].中国卫生标准管理,2016,7(2):160-161.[22]Zhibing R,Jun J,Dingyu M,et al.Multimodality imaging features distinguish pancreatic carcinoma from massforming chronic pancreatitis of the pancreatic head[J].Oncology Letters,2018,15:9735-9744.
相似文献/References:
[1]赵霓姗.胰腺癌主要危险因素及作用机制研究[J].医学信息,2020,33(03):56.[doi:10.3969/j.issn.1006-1959.2020.03.017]
ZHAO Ni-shan.Study on the Main Risk Factors and Mechanism of Pancreatic Cancer[J].Journal of Medical Information,2020,33(17):56.[doi:10.3969/j.issn.1006-1959.2020.03.017]
[2]张文娟,边 伟,王炳超,等.miR-381在胰腺癌患者组织及外周血的表达及临床价值[J].医学信息,2021,34(06):111.[doi:10.3969/j.issn.1006-1959.2021.06.028]
ZHANG Wen-juan,BIAN Wei,WANG Bing-chao,et al.The Expression and Clinical Value of miR-381 in Tissues and Peripheral Blood of Patients with Pancreatic Cancer[J].Journal of Medical Information,2021,34(17):111.[doi:10.3969/j.issn.1006-1959.2021.06.028]
[3]邓裕山,沈国双.AP1基因家族与恶性肿瘤的关系研究[J].医学信息,2022,35(06):56.[doi:10.3969/j.issn.1006-1959.2022.06.014]
DENG Yu-shan,SHEN Guo-shuang.Study on the Relationship Between AP1 Gene Family and Malignant Tumors[J].Journal of Medical Information,2022,35(17):56.[doi:10.3969/j.issn.1006-1959.2022.06.014]
[4]孙惠昕,贾海晗,王婉莹,等.胰腺癌流行现状和影响因素的研究[J].医学信息,2022,35(11):47.[doi:10.3969/j.issn.1006-1959.2022.11.014]
SUN Hui-xin,JIA Hai-han,WANG Wan-ying,et al.The Prevalence and Influencing Factors of Pancreatic Cancer[J].Journal of Medical Information,2022,35(17):47.[doi:10.3969/j.issn.1006-1959.2022.11.014]
[5]漆处梅,唐小龙.胰腺癌患者BZW1和BZW2表达水平及其与预后的相关性分析[J].医学信息,2022,35(21):26.[doi:10.3969/j.issn.1006-1959.2022.21.006]
QI Chu-mei,TANG Xiao-long.Expression of BZW1 and BZW2 in Pancreatic Cancer and its Correlation with Prognosis[J].Journal of Medical Information,2022,35(17):26.[doi:10.3969/j.issn.1006-1959.2022.21.006]
[6]王雨娜,吴冬桂,赵 贝.基于数据挖掘AGR2在胰腺癌中的表达及预后潜力[J].医学信息,2022,35(22):9.[doi:10.3969/j.issn.1006-1959.2022.22.002]
WANG Yu-na,WU Dong-gui,ZHAO Bei.Expression and Prognostic Potential of AGR2 in Pancreatic Cancer Based on Data Mining[J].Journal of Medical Information,2022,35(17):9.[doi:10.3969/j.issn.1006-1959.2022.22.002]
[7]刘 基,孙振纲,邓 岩,等.炎症对胰腺癌患者预后的评估及免疫状态的影响[J].医学信息,2023,36(05):13.[doi:10.3969/j.issn.1006-1959.2023.05.003]
LIU Ji,SUN Zhen-gang,DENG Yan,et al.Effects of Inflammation on Prognosis and Immune Status in Patients with Pancreatic Adenocarcinoma[J].Journal of Medical Information,2023,36(17):13.[doi:10.3969/j.issn.1006-1959.2023.05.003]
[8]石 磊,任婷婷,谭 云,等.基于TOUS胰腺癌术后患者症状群与CRF、生活质量的研究[J].医学信息,2024,37(12):179.[doi:10.3969/j.issn.1006-1959.2024.12.041]
SHI Lei,REN Ting-ting,TAN Yun,et al.Study on Symptom Clusters, CRF and Quality of Life of Postoperative Patients with Pancreatic Cancer Based on TOUS[J].Journal of Medical Information,2024,37(17):179.[doi:10.3969/j.issn.1006-1959.2024.12.041]
[9]卢 琪,尹富生,兰 凯.PI3K/AKT/mTOR通路与胰腺癌发生发展及治疗的研究[J].医学信息,2025,38(02):184.[doi:10.3969/j.issn.1006-1959.2025.02.037]
LU Qi,YIN Fusheng,LAN Kai.Role of PI3K/AKT/mTOR Pathway in the Development and Treatment of Pancreatic Cancer[J].Journal of Medical Information,2025,38(17):184.[doi:10.3969/j.issn.1006-1959.2025.02.037]
[10]王宇路,王苏平,赵雪梅,等.磁共振胰胆管成像对肿块型胰腺炎与胰腺癌的诊断价值[J].医学信息,2021,34(13):176.[doi:10.3969/j.issn.1006-1959.2021.13.049]
WANG Yu-lu,WANG Su-ping,ZHAO Xue-mei,et al.The Value of Magnetic Resonance Cholangiopancreatography in the Differential Diagnosis of Mass Forming ChronicPancreatitis and Pancreatic Cancer[J].Journal of Medical Information,2021,34(17):176.[doi:10.3969/j.issn.1006-1959.2021.13.049]